Investigational Site Number 4024 — St Louis, Missouri

Investigational Site Number 4024 is a clinical research site located in St Louis, Missouri, United States 63110.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

Investigational Site Number 4024 has participated in 1 clinical trials.

Therapeutic areas: Primary Focal Segmental Glomerulosclerosis.

Sponsors: Genzyme, a Sanofi Company.

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Investigational Site Number 4024?

Investigational Site Number 4024 has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Investigational Site Number 4024 conducted?

Investigational Site Number 4024 has 1 clinical trials on record. Their work covers Primary Focal Segmental Glomerulosclerosis.

Is Investigational Site Number 4024 accredited by Crixeo Health?

Investigational Site Number 4024 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Investigational Site Number 4024?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.